Photodynamic theranostics/therapy
(PDT) is a potential strategy
for selectively imaging malignant sites and treating cancer via a
non-invasive therapeutic method. Photosensitizers, the crucial components
of PDT, enable colocalization of photons and light, and photon/light
therapy in the therapeutic window of 400–900 nm exhibits photocytotoxicity
to tumor cells. Due to their high biostability and photocytotoxicity,
nanophotosensitizers (NPSs) are of much interest for malignant
tumor theranostics at present. NPS-activated photons transfer energy
through the absorption of a photon and convert molecular oxygen to
the singlet reactive oxygen species, which leads to apoptosis and
necrosis. Moreover, NPSs modified by polymers, including PLGA, PEG-PLA,
PDLLA, PVCL-g-PLA, and P(VCL-co-VIM)-g-PLA, exhibit excellent biocompatibility, and a tumor-targeting
molecule linked on the nanoparticle surface can precisely deliver
NPSs into the tumor region. The development of NPSs will accelerate
the progress in tumor theranostics through the photon/light pathway.